Group One Trading’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,100
| Closed | -$10.7K | – | 8552 |
|
|
2025
Q1 | $10.7K | Buy |
+6,100
| New | +$8.05K | ﹤0.01% | 6219 |
|
|
2024
Q4 | – | Sell |
-22,600
| Closed | -$35.5K | – | 7848 |
|
|
2024
Q3 | $35.5K | Buy |
22,600
+4,500
| +25% | +$7.45K | ﹤0.01% | 4879 |
|
|
2024
Q2 | $32.3K | Sell |
18,100
-9,100
| -33% | -$21.1K | ﹤0.01% | 4865 |
|
|
2024
Q1 | $78.3K | Buy |
+27,200
| New | +$44.4K | ﹤0.01% | 4355 |
|
|
2022
Q1 | – | Sell |
-370
| Closed | -$1K | – | 8586 |
|
|
2021
Q4 | $1K | Sell |
370
-2,300
| -86% | -$10.2K | ﹤0.01% | 8020 |
|
|
2021
Q3 | $18K | Buy |
2,670
+10
| +0.4% | +$73 | ﹤0.01% | 7237 |
|
|
2021
Q2 | $22K | Buy |
2,660
+2,320
| +682% | +$25.9K | ﹤0.01% | 7128 |
|
|
2021
Q1 | $5K | Buy |
340
+50
| +17% | +$740 | ﹤0.01% | 7241 |
|
|
2020
Q4 | $4K | Buy |
+290
| New | +$2.13K | ﹤0.01% | 6109 |
|
|
2019
Q2 | – | Sell |
-450
| Closed | -$5K | – | 5322 |
|
|
2019
Q1 | $5K | Hold |
450
| – | – | ﹤0.01% | 4446 |
|
|
2018
Q4 | $4K | Buy |
+450
| New | +$7.45K | ﹤0.01% | 4530 |
|
|
2017
Q3 | – | Sell |
-229
| Closed | -$27K | – | 5098 |
|
|
2017
Q2 | $27K | Buy |
229
+21
| +10% | +$3.5K | ﹤0.01% | 3826 |
|
|
2017
Q1 | $41K | Sell |
208
-625
| -75% | -$119K | ﹤0.01% | 3517 |
|
|
2016
Q4 | $225K | Hold |
833
| – | – | ﹤0.01% | 2341 |
|
|
2016
Q3 | $330K | Sell |
833
-244
| -23% | -$100K | ﹤0.01% | 2125 |
|
|
2016
Q2 | $373K | Buy |
1,077
+886
| +464% | +$634K | ﹤0.01% | 1938 |
|
|
2016
Q1 | $159K | Buy |
191
+20
| +12% | +$15.9K | ﹤0.01% | 2490 |
|
|
2015
Q4 | $179K | Sell |
171
-147
| -46% | -$147K | ﹤0.01% | 2571 |
|
|
2015
Q3 | $249K | Sell |
318
-5
| -2% | -$5.13K | ﹤0.01% | 2339 |
|
|
2015
Q2 | $425K | Sell |
323
-625
| -66% | -$1.01M | 0.01% | 1914 |
|
|
2015
Q1 | $1.93M | Buy |
948
+308
| +48% | +$669K | 0.03% | 666 |
|
|
2014
Q4 | $1.23M | Buy |
640
+638
| +31,900% | +$1.13M | 0.02% | 944 |
|
|
2014
Q3 | $1K | Hold |
2
| – | – | ﹤0.01% | 5012 |
|
|
2014
Q2 | $2K | Buy |
+2
| New | +$1.71K | ﹤0.01% | 5011 |
|
Other funds holding RGLS
Group One Trading's RGLS Position: Q2 2024 in Review
Group One Trading sold out of Regulus Therapeutics (RGLS) in Q2 2024, closing a stake of 8,607 shares — an estimated $20K sold.
Group One Trading first reported a position in RGLS in Q4 2014 and held it in 25 quarters. The position peaked at $1.6M in Q1 2015. 63 funds tracked by Wall St. Rank hold RGLS as of Q2 2024.
- Group One Trading reported no remaining Regulus Therapeutics position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 8,607 Regulus Therapeutics shares in Q2 2024, an estimated $20K.
- Group One Trading first reported a position in Regulus Therapeutics in Q4 2014 and held it in 25 quarters.
- Group One Trading's Regulus Therapeutics position peaked at $1.6M in Q1 2015.
- 63 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.